McAndrews, Held & Malloy Secures Victory for Client TQ Delta
McAndrews, Held & Malloy announced that it successfully defended its client TQ Delta against six petitions by 2Wire for inter partes review on patents related to multicarrier communications systems.
McAndrews Facilitated Divestiture of Stem Cell Business of Client Osiris Therapeutics for $100 Million
McAndrews guided client Osiris Therapeutics (NASDAQ:OSIR) in intellectual property matters involving
the sale of Osiris's culture-expanded mesenchymal stem cell (ceMSC) business (including Osiris' large
ceMSC patent estate) to Mesoblast International, SARL (ASX:MSB) (USOTC:MBLTY).
McAndrews’ Client Stryker Corporation Awarded Nearly a Quarter Billion Dollars Following a Jury’s $70 Million Verdict in a Case of Patent Infringement
In Stryker Corp. et al. v. Zimmer, Civil Action No. 10-CV-1223, (W.D. Mich 2013), a jury found for
McAndrews' client Stryker Corporation (NYSE: SYK), one of the world's most innovative medical device
companies.
McAndrews, Held & Malloy Announces Victory for Client Bogies Indoor Golf Club, LLC
McAndrews secured a victory for its client, Bogies Indoor Golf Club, LLC, in a patent infringement lawsuit brought by Golf Simulator, LLC in the U.S. District Court for the Northern District of Illinois.
McAndrews Conducts Critical Due Diligence for RTI Surgical in $130 Million Acquisition that Facilitated RTI’s Foray into a New Market
McAndrews completed a number of critical tasks as advisor to its client RTI Surgical, Inc. (at the time, RTI
Biologics, Inc.)(NYSE: RTIX). RTI was weighing the pros and cons of a $130 million acquisition of medical
device company Pioneer Surgical Technology.
McAndrews Secures Unanimous Appellate Decision in Abbott’s Ongoing Patent Infringement Litigation
In Wyeth and Cordis Corp. v. Abbott Labs, App. Nos. 2012-1223;-1224, the U.S. Court of Appeals for
The Federal Circuit affirmed the U.S. District Court for the District of New Jersey in a case involving drug-eluting stents used in the treatment of coronary artery disease.
McAndrews, Held & Malloy Attorney James P. Murphy Secures Victory in Patent Infringement Lawsuit for Line Power
McAndrews announced a unanimous jury verdict for its client Line Power and its parent company, Bristol, Va.-based Electro-Mechanical Corporation (EMC).
McAndrews Shields Client Cardinal Health from Patent Infringement Charge by Kimberly-Clark
In Kimberly-Clark v. Cardinal Health, Civ. Action No. 11-1228-RGA (D. Del. 2013), a patent case relating
to surgical sterilization wraps, McAndrews' client and defendant Cardinal Health (NYSE: CAH) resolved
its dispute against Kimberly-Clark without incurring a costly litigation and on favorable terms.
McAndrews, Held & Malloy Achieves Pro Bono Victory for the Heartland Alliance's National Immigrant Justice Center
McAndrews succeeded in a pro bono matter by securing asylum for an Iraqi woman and her Egyptian daughter, who fled severe persecution in their home countries and were seeking protection in the United States.
McAndrews, Held & Malloy Files Amicus Brief in Supreme Court Case
Shareholder Scott P. McBride is the Counsel of Record for the Wisconsin Alumni Research Foundation (WARF) in the patent infringement case Bowman v. Monsanto.
